Topic
What is Foundayo (orforglipron)?
Lilly's daily GLP-1 pill: approval, results, side effects, cost.
Foundayo FAQ: 31 Questions About the Orforglipron Pill, AnsweredEvery common question about Foundayo (orforglipron), Eli Lilly's once-daily GLP-1 pill, answered from the FDA label, the Phase 3 trials and Lilly's own published terms. Approval, doses, food rules, side effects, cost, coverage, switching and what is still unknown.Foundayo Results: How Much Weight People Actually Lost in the TrialsFoundayo's headline number is 27.3 pounds, or 12.4%, over 72 weeks at the top dose. But there are three different ways that trial has been reported, and the number changes each time. Here is every published Foundayo result with the numbers, the timeline, and what the studies do not show.Foundayo Side Effects: What the Label and Trials Actually ReportNausea, constipation, diarrhea and vomiting are the side effects most people on Foundayo (orforglipron) report, and the FDA label puts hard numbers on each one by dose. Here is the full list, how common each one was, what the serious warnings say, and what patients describe in the real world.Foundayo vs. the Wegovy Pill: How the Two GLP-1 Tablets CompareFoundayo (orforglipron) and the Wegovy pill (oral semaglutide 25 mg) are the only two GLP-1 tablets approved in the US for weight management. They differ on how you take them, how much weight they produced in trials, what else they are approved to do, and what they cost.How Much Does Foundayo Cost in 2026? Self-Pay, Insurance and MedicareFoundayo (orforglipron) has no single price. Lilly charges by dose, from $149 to $349 a month for self-pay, about $25 a month with commercial insurance that covers it, and $50 a month through the Medicare GLP-1 Bridge. Here is every published price, where each one applies, and the traps people keep hitting.What Is Foundayo (Orforglipron)? The GLP-1 Pill ExplainedFoundayo is Eli Lilly's once-daily GLP-1 pill for weight management, approved by the FDA on April 1, 2026. Here is what it is, how it works, what the label says about doses, and how it differs from every other GLP-1 on the market.